Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Saint Louis University has 3 pending office actions in Biotechnology & Pharmaceuticals. The portfolio spans 3 distinct examiners and 3 distinct art units, requiring matter-specific tracking rather than a single prosecution approach.
HILL, MYRON G is the busiest examiner, with 1 pending matter. That action should be managed alongside the two matters assigned to other examiners and units, with separate analysis of each record.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| §112 only | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HILL, MYRON G | 1 | 66.1% | +20.7% |
| WILLIS, DOUGLAS M | 1 | 82.4% | +19.7% |
| GHIMIRE, SHANKAR RAJ | 1 | 76.7% | +19.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18001148 | ARYLACETAMIDE ANALOGS OF PIPERAZINE-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINES | WILLIS, DOUGLAS M | 37d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18001148 | ARYLACETAMIDE ANALOGS OF PIPERAZINE-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINES | WILLIS, DOUGLAS M | 37d overdue |
| 18061047 | URINARY CATHETER FOR ENDOSCOPE | GHIMIRE, SHANKAR RAJ | 28d |
| 18160926 | HEPATITIS C VIRUS MODIFIED E2 GLYCOPROTEIN AND USES THEREOF AS VACCINES | HILL, MYRON G | — |
| Art Unit | Apps |
|---|---|
| 1671 | 1 |
| 1624 | 1 |
| 3795 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18160926 | HEPATITIS C VIRUS MODIFIED E2 GLYCOPROTEIN AND USES THEREOF AS VACCINES | HILL, MYRON G | 1671 | §112 | Final Rejection | — | Pending | Jan 27, 2023 |
| 18001148 | ARYLACETAMIDE ANALOGS OF PIPERAZINE-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINES | WILLIS, DOUGLAS M | 1624 | §112 | Non-Final OA | 37d overdue | Pending | Dec 08, 2022 |
| 18061047 | URINARY CATHETER FOR ENDOSCOPE | GHIMIRE, SHANKAR RAJ | 3795 | §103 | Final Rejection | 28d | Pending | Dec 02, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSaint Louis University has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Myron G Hill has the most, with 1 of Saint Louis University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
